jobst opaque class 2 (23-32mmhg) tights closed toe lymphoedema garment regular size iv
23-32mmhg) tights closed toe lymphoedema garment regular size iv natural (bsn medical ltd -
jobst ultrasheer class 2 (23-32mmhg) tights closed toe lymphoedema garment regular size iv
23-32mmhg) tights closed toe lymphoedema garment regular size iv natural (bsn medical ltd -
betaloc cr 23.75
astrazeneca limited - metoprolol succinate 23.75mg; - modified release tablet - 23.75 mg - active: metoprolol succinate 23.75mg excipient: ethylcellulose hydrated silica hyprolose hypromellose liquid paraffin macrogol 6000 microcrystalline cellulose sodium stearyl fumarate titanium dioxide - · hypertension. to reduce blood pressure and to reduce the risk of cardiovascular and coronary mortality (including sudden death), and morbidity. · angina pectoris. · symptomatic mild to severe chronic heart failure as an adjunct to other heart failure therapy to: increase survival, reduce hospitalisation, improve left ventricular function, improve new york heart association (nyha) functional class and improve quality of life. · cardiac arrhythmias, especially supraventricular tachycardia, reduction of ventricular rate in atrial fibrillation and ventricular extrasystoles. · maintenance treatment after myocardial infarction · hyperthyroidism. · functional heart disorder with palpitations. · migraine prophylaxis. · paediatric hypertension
23-valent pneumococcal polysaccharide vaccine injection
23-valent pneumococcal polysaccharide vaccine - injection - 0.5ml/dose/syringe which consists of 23 serotypes - vaccines
medical oxygen
boc gases ireland ltd - oxygen - medicinal gas, compressed - 99.5 percent volume/volume - medical gases; oxygen
pneumovax 23 vaccine
merck sharp & dohme (new zealand) limited - pneumococcal polysaccharide vaccine 50 µg/ml (25mcg/dose of each of 23 named pneumococcal polysaccharides) - solution for injection - active: pneumococcal polysaccharide vaccine 50 µg/ml (25mcg/dose of each of 23 named pneumococcal polysaccharides) excipient: phenol sodium chloride water for injection - pneumovax 23 is indicated for vaccination against pneumococcal disease caused by those pneumococcal types included in the vaccine.
minax xl metoprolol succinate 23.75 mg modified release tablet blister pack
alphapharm pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: hypromellose; microcrystalline cellulose; macrogol 400; ethylcellulose; sodium stearylfumarate; macrogol 6000; colloidal anhydrous silica; titanium dioxide; lactose monohydrate; triacetin - stable, chronic heart failure as an adjunct to other heart failure therapy.
metrol-xl 23.75 metoprolol succinate 23.75 mg modified release tablet blister pack
arrotex pharmaceuticals pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: titanium dioxide; glycerol; magnesium stearate; microcrystalline cellulose; stearic acid; ethylcellulose; maize starch; hypromellose; methylcellulose - stable, chronic heart failure as an adjunct to other heart failure therapy.
toprol-xl metoprolol succinate 23.75mg controlled release tablet blister pack
astrazeneca pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: silicon dioxide; ethylcellulose; hyprolose; microcrystalline cellulose; sodium stearylfumarate; synthetic paraffin; macrogol 6000; hypromellose; titanium dioxide - stable, chronic heart failure as an adjunct to other heart failure therapy.
tobeta-xl metoprolol succinate 23.75 mg modified release tablet bottle pack
pharmacor pty ltd - metoprolol succinate, quantity: 23.75 mg - tablet, modified release - excipient ingredients: microcrystalline cellulose; ethylcellulose; triethyl citrate; silicified microcrystalline cellulose; methacrylic acid copolymer; sodium stearylfumarate; macrogol 6000; povidone; purified talc; croscarmellose sodium; silicon dioxide; titanium dioxide; hypromellose; peg-150 distearate; lauromacrogol 400 - stable, chronic heart failure as an adjunct to other heart failure therapy.